Comparison of clinical scoring systems in aggressive B-cell lymphomas (BCL): An individual patient-level analysis across international trials (SEAL).

Amy S. Ruppert,Jesse G. Dixon,Gilles Salles,Anna Wall,David Cunningham,Viola Poeschel,Corinne Haioun,Hervé Tilly,Hervé Ghesquières,Marita Ziepert,Jocelyne Flament,Christopher R. Flowers,Qian Shi,Norbert Shmitz

Comparison of clinical scoring systems in aggressive B-cell lymphomas (BCL): An individual patient-level analysis across international trials (SEAL).

2019

Amy S. Ruppert
Jesse G. Dixon
Gilles Salles
Anna Wall
David Cunningham
Viola Poeschel
Corinne Haioun
Hervé Tilly
Hervé Ghesquières
Marita Ziepert
Jocelyne Flament
Christopher R. Flowers
Qian Shi
Norbert Shmitz

7544Background: Great heterogeneity in survival exists for patients (pts) newly diagnosed with aggressive BCL. Three scoring systems based on simple clinical parameters (age, lactate dehydrogenase,...

Keywords:

Pathology
Oncology
Internal medicine
B cell
Lactate dehydrogenase
Medicine
newly diagnosed

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations